These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34380564)

  • 1. Established and candidate transthyretin amyloidosis variants identified in the Saudi population by data mining.
    Abouelhoda M; Mohty D; Alayary I; Meyer BF; Arold ST; Fadel BM; Monies D
    Hum Genomics; 2021 Aug; 15(1):52. PubMed ID: 34380564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of genetic amyloidosis through the analysis of transthyretin gene mutation using high-resolution melting.
    Lahuerta C; Menao S; Gracia-Gutierrez A; Bueno-Juana E; Guillén N; Sorribas V; Gracia AA; Aibar MA
    Int J Cardiol; 2020 Feb; 301():220-225. PubMed ID: 31740141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis.
    Brown EE; Lee YZJ; Halushka MK; Steenbergen C; Johnson NM; Almansa J; Tedford RJ; Cingolani O; Russell SD; Sharma K; Judge DP
    Amyloid; 2017 Jun; 24(2):92-95. PubMed ID: 28494620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
    Sekijima Y
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.
    Yamashita T; Ueda M; Misumi Y; Masuda T; Nomura T; Tasaki M; Takamatsu K; Sasada K; Obayashi K; Matsui H; Ando Y
    J Neurol; 2018 Jan; 265(1):134-140. PubMed ID: 29177547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
    Coelho T; Maurer MS; Suhr OB
    Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele specific expression of the transthyretin gene in swedish patients with hereditary transthyretin amyloidosis (ATTR V30M) is similar between the two alleles.
    Norgren N; Hellman U; Ericzon BG; Olsson M; Suhr OB
    PLoS One; 2012; 7(11):e49981. PubMed ID: 23185504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DISCOVERY: prevalence of transthyretin (
    Akinboboye O; Shah K; Warner AL; Damy T; Taylor HA; Gollob J; Powell C; Karsten V; Vest J; Maurer MS
    Amyloid; 2020 Dec; 27(4):223-230. PubMed ID: 32456532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).
    Phull P; Sanchorawala V; Connors LH; Doros G; Ruberg FL; Berk JL; Sarosiek S
    Amyloid; 2018 Mar; 25(1):62-67. PubMed ID: 29424556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New sequence variants in patients affected by amyloidosis show transthyretin instability by isoelectric focusing.
    Hinderhofer K; Obermaier C; Hegenbart U; Schönland S; Seidler M; Sommer-Ort I; Barth U
    Amyloid; 2019 Jun; 26(2):85-93. PubMed ID: 31074293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology.
    Skrahina V; Grittner U; Beetz C; Skripuletz T; Juenemann M; Krämer HH; Hahn K; Rieth A; Schaechinger V; Patten M; Tanislav C; Achenbach S; Assmus B; Knebel F; Gingele S; Skrahin A; Hartkamp J; Förster TM; Roesner S; Pereira C; Rolfs A
    Ann Med; 2021 Dec; 53(1):1787-1796. PubMed ID: 34658264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan.
    Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y
    Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy.
    Porcari A; Razvi Y; Masi A; Patel R; Ioannou A; Rauf MU; Hutt DF; Rowczenio D; Gilbertson J; Martinez-Naharro A; Venneri L; Whelan C; Lachmann H; Wechalekar A; Quarta CC; Merlo M; Sinagra G; Hawkins PN; Fontana M; Gillmore JD
    Eur J Heart Fail; 2023 Apr; 25(4):515-524. PubMed ID: 36644836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequencies and geographic distributions of genetic mutations in transthyretin- and non-transthyretin-related familial amyloidosis.
    Zhen DB; Swiecicki PL; Zeldenrust SR; Dispenzieri A; Mauermann ML; Gertz MA
    Clin Genet; 2015 Oct; 88(4):396-400. PubMed ID: 25211232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel transthyretin variant p.H110D (H90D) as a cause of familial amyloid polyneuropathy in a large Irish kindred.
    Jimenez-Zepeda VH; Bahlis NJ; Gilbertson J; Rendell N; Porcari R; Lachmann HJ; Gillmore JD; Hawkins PN; Rowczenio DM
    Amyloid; 2015 Mar; 22(1):26-30. PubMed ID: 25430583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Outcomes of p.Val142Ile
    Chandrashekar P; Alhuneafat L; Mannello M; Al-Rashdan L; Kim MM; Dungu J; Alexander K; Masri A
    Circ Genom Precis Med; 2021 Oct; 14(5):e003356. PubMed ID: 34461737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).
    Klaassen SHC; Lemmink HH; Bijzet J; Glaudemans AWJM; Bos R; Plattel W; van den Berg MP; Slart RHJA; Nienhuis HLA; van Veldhuisen DJ; Hazenberg BPC
    Cardiovasc Pathol; 2017; 29():19-22. PubMed ID: 28460244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
    Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
    Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transthyretin amyloidosis: a phenocopy of hypertrophic cardiomyopathy.
    Vermeer AMC; Janssen A; Boorsma PC; Mannens MMAM; Wilde AAM; Christiaans I
    Amyloid; 2017 Jun; 24(2):87-91. PubMed ID: 28475415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis.
    Gopal DM; Ruberg FL; Siddiqi OK
    Curr Heart Fail Rep; 2019 Oct; 16(5):180-188. PubMed ID: 31520266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.